Kanchanaburi, May 2007 A collaboration between: SMRU, MSF-F, AMI, IRC, ARC, MHD With the participation of TBBC and HIS/CCSDPT Malaria surveillance in camps.

Slides:



Advertisements
Similar presentations
MICS3 Data Analysis and Report Writing
Advertisements

HIV/AIDS Estimation and Projections: Overview of Methods and Activities.
Sexually transmitted infections: epidemiological evidence of need Dr Kirsty Foster Consultant in Health Protection Public Health England Centre, North.
Spectacular decline of malaria on Malaita: A review of laboratory-based data Helen Polosovai BApplSc(MedLab) AAH Laboratory Dept.
Malaria treatment (Current WHO recommendations & guidelines)
Referral of participants for HIV follow-up care Africa Centre MDP experiences Presented by: Hlengiwe Ndlovu MDP Clinic coordinator.
National Malaria Centre of Cambodia Rational Pharmaceutical Management Plus Program World Health Organization European Commission Cambodian Malaria Control.
Measuring access to diagnosis and treatment RBM-CMWG July 9, 2009 Richard Steketee, MACEPA-PATH RBM-MERG Co-Chair.
Mortality and causes of death among women living with HIV in the UK in the era of highly-active antiretroviral therapy Sara Croxford, A Kitching, M Kall,
HIV in the United Kingdom: 2013 HIV and AIDS Reporting Section Centre for Infectious Disease Surveillance and Control (CIDSC) Public Health England London,
By Victor Chalwe, MD, MSC. ICIUM, Turkey.  The home management of malaria strategy is a WHO tool that identifies high risks groups such as children and.
1. Health Policy Research Group Department of Pharmacology & Therapeutics, College of Medicine, University of Nigeria Enugu Campus 2. Department of Clinical.
Current Malaria Situation -Bangladesh MALARIA FACTS Country Area 147,570 sq. km and Pop million 13 out of 64 districts are high endemic 13.3 million.
KINGDOM OF CAMBODIA Ministry of Health National Center for Parasitology, Entomology and Malaria Control CNM.
Country report-Tanzania Presented to EARN Annual Malaria Conference Kigali, Rwanda 15th –19 th November, 2004 NMCP.
Module 1: Final Case Study #1-CS-1. Case Study: Instructions v Try this case study individually. v We’ll discuss the answers in class. # 1-CS-2.
World Health Organization
Choice of antimalarial drugs Malaria Medicines & Supplies Services RBM Partnership Secretariat.
Module 3: Final Case Study # 3-CS-1. Case Study: Instructions v Try this case study individually. v We’ll discuss the answers in class. # 3-CS-2.
Mortality rates Ashry Gad Mohamed Prof. Ashry Gad Mohamed.
Anti-Malaria Drug Policy Philippines
Malaria Situation & Drug Policy Malaysia Infectious Disease Consultant/Physician MOH Malaysia.
1 Local resistance management and containment response Dr Wichai Satimai: Director, Bureau of Vector Borne Diseases, Department of Disease Control, Ministry.
PREVENTION OF MOTHER-TO-CHILD TRANSMISSION OF HIV WHAT’S NEW Prepared by Dr. Debbie Carrington National HIV/AIDS Prevention & Control Programme Ministry.
Background Objective Methods Results Discussion Assessing the Risk of Self- diagnosed Malaria in Urban Informal Settlements Yazoumé Yé Elizabeth Kimani.
Sue Hawkins Care Catering Services Manager Malnutrition Task Force Update Prevention and early intervention of malnutrition in later life.
STI surveillance Belgium Results and recommandations Ruth Verbrugge WIV-ISP th STI-HIV seminar 9 th STI-HIV seminar.
Models of Care for Paediatric HIV Miriam Chipimo MD MPH Reproductive Health & HIV&AIDS Manager, UNICEF, Malawi.
Introduction About HIV/AIDS in Hangzhou Hangzhou Center For Disease Control And Prevention — by Zhao Gang — by Zhao Gang.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System HIV in the United Kingdom: 2012 Overview.
1 Malaria Prevention and Control in Ethiopia Dr Daddi Jima National Malaria Control Program, Ethiopia.
Malaria--Background Occurs in > 90 countries million cases a year 2 million deaths a year –>90% deaths in sub-Saharan Africa –Most deaths in children.
1 Novel Influenza A H1N1 Outbreak: The Florida Response Epidemiology Perspective: Situation Update.
Current National Drug Policies in Lao P.D.R. By Dr Samlane Phompida Centre of Malariology, Parasitology & Entomology.
TB epidemiology in Thailand Philippe Glaziou, on behalf of the epi team Bangkok, August 2013.
Issues in malaria diagnosis and treatment May 31, 2007 Jacek Skarbinski, MD Malaria Branch Centers for Disease Control and Prevention.
Unit 6: Second-Generation HIV/AIDS Surveillance #1-6-1.
Recent Epidemiologic Situations of TB in Myanmar -Preliminary Review of Data from routine TB surveillance focusing on Case Finding- 9 May 2014, Nay Pyi.
Keeping up with the epidemic Programme success leaves us with new challenges: An evaluation of programmes for injecting sex workers.
Australia’s response and activities Rhonda Owen August 2009 PANDEMIC (H1N1) 2009.
MDG 4 Target: Reduce by two- thirds, between 1990 & 2015, the mortality rate of children under five years.
Integration of collaborative TB/HIV activities with harm reduction services Maryna Zelenskaya Ph D State service on HIV/AIDS and other socially diseases.
An update of artemisinin resistance and its containment efforts
MSF TB Program for Migrants in Tak. Beginnings: MSF TB Programs in Thailand First MSF TB Program in Thailand started in 1985 in Karen camps (Shoklo,
SOP for malaria case surveillance
AMI -RAVREDA – USAID Project report, Colombia March 2009 Preliminary results on efficacy and Safety of Coartem ® on the treatment of Acute Uncomplicated.
Providing Care and Treatment for HIV Sero-convertors in the Cellulose Sulfate Trial Issues for discussion Preparation process for care and treatment of.
1 EPI services for migrant populations in Tak province.
+ Quality Assessment of Malaria Diagnosis on the Thai-Burma Border Jaime Moo-Young Noon Conference, Harborview Medical Center June 1, 2010.
"Epidemiological Features of Rotavirus Infection among children below 5 years old in Jordan, Rationale for Vaccine Introduction,2015" Kareman Juma`ah Al-Zain.
Is antimalarial treatment in pregnant women as effective as that in non- pregnant women? Elizabeth Juma, Rashid Aman, Florence Oloo, Bernhards Ogutu Centre.
M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 28 – Consumer and Health Protection.
A Call to Action Children – The missing face of AIDS.
Effect of ART on malaria parasitaemia and clinical episodes in adults in rural Uganda: A population-based cohort study Billy N. Mayanja 1, Kathy Baisley.
Bureau of Vector Borne Disease Control, Thailand. TES result in
Outline of Current Situation Survey on HIV/AIDS (Proposal) Ms. Keiko Dozono Director for AIDS and Emerging Infectious Disease Control Health and Safety.
2007 Pan American Health Organization 2004 Pan American Health Organization Malaria in the Americas: Progress, Challenges, Strategies and Main Activities.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Pakistan Last updated: November 2014.
TB AND HIV: “THE STRATEGIC VISION FOR THE COUNTRY” Dr Lindiwe Mvusi 18 May 2012 MMPA Congress 2012.
Malaria Elimination Programme Timor Leste
Unit 6: Second-Generation HIV/AIDS Surveillance
A COLLABORATIVE APPROACH TO ESTABLISH PREDICTORS
Content Public Health Emergencies Lassa Fever: Nigeria
Content Public Health Emergencies Ebola Virus Disease: DRC
Content Public Health Emergencies Ebola Virus Disease: DRC
Dr.Merita Monteiro Head of CDC Ministry of Health Timor Leste
China 2010 UNGASS Country Progress Report
Content Public Health Emergencies Lassa Fever: Nigeria
WHO Community drug use practices in malaria in Cambodia: a cross-sectional study National Malaria Centre of Cambodia Rational Pharmaceutical Management.
Trends in the HIV incidence rate following ART scale-up in a rural and hyper-endemic South Africa population (2004–2015) Alain Vandormael, PhD School of.
Presentation transcript:

Kanchanaburi, May 2007 A collaboration between: SMRU, MSF-F, AMI, IRC, ARC, MHD With the participation of TBBC and HIS/CCSDPT Malaria surveillance in camps for displaced population and migrants: Thai-Myanmar border

Camps situation: Background 1984: 7 camps in Tak province, 10,000 persons 1994: 32 camps from Mae Hong Son to Chumpon provinces, 77,000 persons During that period: Frequent malaria outbreaks during camps relocation 40% of total consultations due to malaria 1 st cause of mortality in the camps 1% of pregnant women dying of malaria each year 80% of malaria due to P. falciparum

Cure Rate (%) CQ SP M 25 M 15 Years P. falciparum resistance to antimalarials (Fansidar) (Mefloquine) (Chloroquine) : First MAS trials 1994: MAS 3 in the camps

Established in mid-1995 to control epidemics and to develop a coherent malaria control program in the camps based on: –Weekly surveillance system –Reliable laboratory diagnosis with Q.C. –Unique treatment guideline based on mefloquine and artesunate combination therapy and regular update on new protocols Malaria Task Force

Total camps Total population a 87,499120,080149,001 Camps reporting to MTF Population covered by MTF (in % of total popul) 83,344 (95.3%) 119,804 (99.8%) 137,934 (92.6%) a Population as reported by the Thai Burmese Border Consortium (TBBC) monthly report Population coverage Bangkok

Malaria morbidity & mortality Total consultations (all causes) * 163,346 * 551,506578,231 Malaria consultations (in % of total consult) 38,702 (23.7%) 15,079 (2.7%) 17,346 (3.0%) PF / 1,000 persons PV / 1,000 persons Malaria deaths (in % of total deaths) 41 (9.9%) 7 (2.3%) 3 (0.6%) * Probably underestimated, as some camps reported fever cases only

Malaria cases per 1,000 residents

Ratio PF/PV by age group

Ratio PF/PV in adults of Mae La

P. falciparum distribution by sex Mae La camp: adults

Malaria cases in clinics for migrant workers

ED and MAS 3 in the camps % of consultations 1 malaria case/person/yr 24% of all deaths : ACT in all camps ~ 25% of consultations 0.5 malaria case/person/yr 10% of all deaths % of consultations 0.1 malaria case/person/yr 3% of all deaths % of consultations 0.1 malaria case/person/yr <1 % of all deaths

Malaria prevalence in migrant workers – May 07 < 5yrs old5-15yrs old> 15yrs old MaleFemaleMaleFemaleMaleFemale Total screened PF00 1 (1.8%) 1 (1.7%) 4 (6.2%) 3 (2.7%) PV/PM/PO 3 (6.8%) 1 (3.3%) 5 (8.8%) 2 (3.4%) 8 (12.3%) 4 (3.6%) (2006: PF 9.8% - PV 6.5%)

MAS efficacy

Conclusion No epidemics since 1997 in the camps for displaced population 4-fold reduction in malaria PF since 1996 in camps MAS still effective PF remains among the adult male population, particularly among those leaving the camps overnight and the migrants THEREFORE Malaria surveillance and regular reporting still needed especially in the mobile population Collaborative effort on both sides of the border necessary MAS efficacy monitoring essential

Thanks to: All laboratory teams & HIS officers for their timely contribution to the MTF weekly surveillance system Miss Kerala for collecting, storing and computerizing all those reports